Easy Access and Express Report Delivery Service
Small Nucleic Acid Drug Market, Global Outlook and Forecast 2023-2029
Report ID
42796
Publisher
Market Monitor Global
Published Date
07-Dec
Delivery Format
PDF
No of Report Page
126
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Small Nucleic Acid Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Small Nucleic Acid Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Small Nucleic Acid Drug, challenges faced by the industry, and potential opportunities for market players. The global Small Nucleic Acid Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Small Nucleic Acid Drug market presents opportunities for various stakeholders, including Neuromuscular Diseases, hATTR. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Small Nucleic Acid Drug market. Additionally, the growing consumer demand present avenues for market expansion. The global Small Nucleic Acid Drug market was valued at US$ 3818.1 million in 2022 and is projected to reach US$ 15400 million by 2029, at a CAGR of 22.4% during the forecast period. The Small Nucleic Acid Drug Market is driven by the transformative potential of small nucleic acids, including microRNA, aptamers, and small interfering RNA (siRNA), in treating a wide spectrum of diseases, from genetic disorders to cancer and viral infections. These therapies harness the power of small nucleic acids to modulate gene expression, inhibit specific targets, and diagnose diseases, offering a precise and personalized approach to treatment. As genomics and RNA-based research advance, and precision medicine gains prominence, the demand for small nucleic acid drugs continues to surge. Innovations in nucleic acid design, delivery systems, and gene-editing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to overcome hurdles related to safe and efficient drug delivery, minimize off-target effects, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Addressing delivery challenges, optimizing pharmacokinetics, and managing development costs are ongoing hurdles. Additionally, the market faces competition from traditional therapeutic approaches, necessitating continuous research and development efforts to unlock the full therapeutic potential of small nucleic acid drugs. Striking a balance between providing safe, effective, and accessible small nucleic acid therapies while addressing scientific and regulatory challenges is paramount for the continued growth of the Small Nucleic Acid Drug Market. Key Features: The research report on the Small Nucleic Acid Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Small Nucleic Acid Drug market. Market Overview: The report provides a comprehensive overview of the Small Nucleic Acid Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antisense Oligonucleotides (ASO), siRNA), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Small Nucleic Acid Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Small Nucleic Acid Drug market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Small Nucleic Acid Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Small Nucleic Acid Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Small Nucleic Acid Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Small Nucleic Acid Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Small Nucleic Acid Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Small Nucleic Acid Drug market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Small Nucleic Acid Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type Antisense Oligonucleotides (ASO) siRNA Other Market segment by Application Neuromuscular Diseases hATTR Other Global Small Nucleic Acid Drug Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Sarepta Therapeutics Ionis Pharmaceuticals Alnylam Biogen Nippon Shinyaku Sobi Novartis Jazz Pharmaceuticals CureVac Regulus Therapeutics ProQR Secarna MiNA Therapeutics Sylentis Arrowhead Silence Therapeutics Dicerna Outline of Major Chapters: Chapter 1: Introduces the definition of Small Nucleic Acid Drug, market overview. Chapter 2: Global Small Nucleic Acid Drug market size in revenue. Chapter 3: Detailed analysis of Small Nucleic Acid Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Small Nucleic Acid Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Small Nucleic Acid Drug Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Small Nucleic Acid Drug Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Small Nucleic Acid Drug Overall Market Size 2.1 Global Small Nucleic Acid Drug Market Size: 2022 VS 2029 2.2 Global Small Nucleic Acid Drug Market Size, Prospects & Forecasts: 2018-2029 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Small Nucleic Acid Drug Players in Global Market 3.2 Top Global Small Nucleic Acid Drug Companies Ranked by Revenue 3.3 Global Small Nucleic Acid Drug Revenue by Companies 3.4 Top 3 and Top 5 Small Nucleic Acid Drug Companies in Global Market, by Revenue in 2022 3.5 Global Companies Small Nucleic Acid Drug Product Type 3.6 Tier 1, Tier 2 and Tier 3 Small Nucleic Acid Drug Players in Global Market 3.6.1 List of Global Tier 1 Small Nucleic Acid Drug Companies 3.6.2 List of Global Tier 2 and Tier 3 Small Nucleic Acid Drug Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Small Nucleic Acid Drug Market Size Markets, 2022 & 2029 4.1.2 Antisense Oligonucleotides (ASO) 4.1.3 siRNA 4.1.4 Other 4.2 By Type - Global Small Nucleic Acid Drug Revenue & Forecasts 4.2.1 By Type - Global Small Nucleic Acid Drug Revenue, 2018-2023 4.2.2 By Type - Global Small Nucleic Acid Drug Revenue, 2024-2029 4.2.3 By Type - Global Small Nucleic Acid Drug Revenue Market Share, 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Small Nucleic Acid Drug Market Size, 2022 & 2029 5.1.2 Neuromuscular Diseases 5.1.3 hATTR 5.1.4 Other 5.2 By Application - Global Small Nucleic Acid Drug Revenue & Forecasts 5.2.1 By Application - Global Small Nucleic Acid Drug Revenue, 2018-2023 5.2.2 By Application - Global Small Nucleic Acid Drug Revenue, 2024-2029 5.2.3 By Application - Global Small Nucleic Acid Drug Revenue Market Share, 2018-2029 6 Sights by Region 6.1 By Region - Global Small Nucleic Acid Drug Market Size, 2022 & 2029 6.2 By Region - Global Small Nucleic Acid Drug Revenue & Forecasts 6.2.1 By Region - Global Small Nucleic Acid Drug Revenue, 2018-2023 6.2.2 By Region - Global Small Nucleic Acid Drug Revenue, 2024-2029 6.2.3 By Region - Global Small Nucleic Acid Drug Revenue Market Share, 2018-2029 6.3 North America 6.3.1 By Country - North America Small Nucleic Acid Drug Revenue, 2018-2029 6.3.2 US Small Nucleic Acid Drug Market Size, 2018-2029 6.3.3 Canada Small Nucleic Acid Drug Market Size, 2018-2029 6.3.4 Mexico Small Nucleic Acid Drug Market Size, 2018-2029 6.4 Europe 6.4.1 By Country - Europe Small Nucleic Acid Drug Revenue, 2018-2029 6.4.2 Germany Small Nucleic Acid Drug Market Size, 2018-2029 6.4.3 France Small Nucleic Acid Drug Market Size, 2018-2029 6.4.4 U.K. Small Nucleic Acid Drug Market Size, 2018-2029 6.4.5 Italy Small Nucleic Acid Drug Market Size, 2018-2029 6.4.6 Russia Small Nucleic Acid Drug Market Size, 2018-2029 6.4.7 Nordic Countries Small Nucleic Acid Drug Market Size, 2018-2029 6.4.8 Benelux Small Nucleic Acid Drug Market Size, 2018-2029 6.5 Asia 6.5.1 By Region - Asia Small Nucleic Acid Drug Revenue, 2018-2029 6.5.2 China Small Nucleic Acid Drug Market Size, 2018-2029 6.5.3 Japan Small Nucleic Acid Drug Market Size, 2018-2029 6.5.4 South Korea Small Nucleic Acid Drug Market Size, 2018-2029 6.5.5 Southeast Asia Small Nucleic Acid Drug Market Size, 2018-2029 6.5.6 India Small Nucleic Acid Drug Market Size, 2018-2029 6.6 South America 6.6.1 By Country - South America Small Nucleic Acid Drug Revenue, 2018-2029 6.6.2 Brazil Small Nucleic Acid Drug Market Size, 2018-2029 6.6.3 Argentina Small Nucleic Acid Drug Market Size, 2018-2029 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Small Nucleic Acid Drug Revenue, 2018-2029 6.7.2 Turkey Small Nucleic Acid Drug Market Size, 2018-2029 6.7.3 Israel Small Nucleic Acid Drug Market Size, 2018-2029 6.7.4 Saudi Arabia Small Nucleic Acid Drug Market Size, 2018-2029 6.7.5 UAE Small Nucleic Acid Drug Market Size, 2018-2029 7 Small Nucleic Acid Drug Companies Profiles 7.1 Sarepta Therapeutics 7.1.1 Sarepta Therapeutics Company Summary 7.1.2 Sarepta Therapeutics Business Overview 7.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Major Product Offerings 7.1.4 Sarepta Therapeutics Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.1.5 Sarepta Therapeutics Key News & Latest Developments 7.2 Ionis Pharmaceuticals 7.2.1 Ionis Pharmaceuticals Company Summary 7.2.2 Ionis Pharmaceuticals Business Overview 7.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Major Product Offerings 7.2.4 Ionis Pharmaceuticals Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.2.5 Ionis Pharmaceuticals Key News & Latest Developments 7.3 Alnylam 7.3.1 Alnylam Company Summary 7.3.2 Alnylam Business Overview 7.3.3 Alnylam Small Nucleic Acid Drug Major Product Offerings 7.3.4 Alnylam Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.3.5 Alnylam Key News & Latest Developments 7.4 Biogen 7.4.1 Biogen Company Summary 7.4.2 Biogen Business Overview 7.4.3 Biogen Small Nucleic Acid Drug Major Product Offerings 7.4.4 Biogen Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.4.5 Biogen Key News & Latest Developments 7.5 Nippon Shinyaku 7.5.1 Nippon Shinyaku Company Summary 7.5.2 Nippon Shinyaku Business Overview 7.5.3 Nippon Shinyaku Small Nucleic Acid Drug Major Product Offerings 7.5.4 Nippon Shinyaku Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.5.5 Nippon Shinyaku Key News & Latest Developments 7.6 Sobi 7.6.1 Sobi Company Summary 7.6.2 Sobi Business Overview 7.6.3 Sobi Small Nucleic Acid Drug Major Product Offerings 7.6.4 Sobi Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.6.5 Sobi Key News & Latest Developments 7.7 Novartis 7.7.1 Novartis Company Summary 7.7.2 Novartis Business Overview 7.7.3 Novartis Small Nucleic Acid Drug Major Product Offerings 7.7.4 Novartis Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.7.5 Novartis Key News & Latest Developments 7.8 Jazz Pharmaceuticals 7.8.1 Jazz Pharmaceuticals Company Summary 7.8.2 Jazz Pharmaceuticals Business Overview 7.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Major Product Offerings 7.8.4 Jazz Pharmaceuticals Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.8.5 Jazz Pharmaceuticals Key News & Latest Developments 7.9 CureVac 7.9.1 CureVac Company Summary 7.9.2 CureVac Business Overview 7.9.3 CureVac Small Nucleic Acid Drug Major Product Offerings 7.9.4 CureVac Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.9.5 CureVac Key News & Latest Developments 7.10 Regulus Therapeutics 7.10.1 Regulus Therapeutics Company Summary 7.10.2 Regulus Therapeutics Business Overview 7.10.3 Regulus Therapeutics Small Nucleic Acid Drug Major Product Offerings 7.10.4 Regulus Therapeutics Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.10.5 Regulus Therapeutics Key News & Latest Developments 7.11 ProQR 7.11.1 ProQR Company Summary 7.11.2 ProQR Business Overview 7.11.3 ProQR Small Nucleic Acid Drug Major Product Offerings 7.11.4 ProQR Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.11.5 ProQR Key News & Latest Developments 7.12 Secarna 7.12.1 Secarna Company Summary 7.12.2 Secarna Business Overview 7.12.3 Secarna Small Nucleic Acid Drug Major Product Offerings 7.12.4 Secarna Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.12.5 Secarna Key News & Latest Developments 7.13 MiNA Therapeutics 7.13.1 MiNA Therapeutics Company Summary 7.13.2 MiNA Therapeutics Business Overview 7.13.3 MiNA Therapeutics Small Nucleic Acid Drug Major Product Offerings 7.13.4 MiNA Therapeutics Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.13.5 MiNA Therapeutics Key News & Latest Developments 7.14 Sylentis 7.14.1 Sylentis Company Summary 7.14.2 Sylentis Business Overview 7.14.3 Sylentis Small Nucleic Acid Drug Major Product Offerings 7.14.4 Sylentis Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.14.5 Sylentis Key News & Latest Developments 7.15 Arrowhead 7.15.1 Arrowhead Company Summary 7.15.2 Arrowhead Business Overview 7.15.3 Arrowhead Small Nucleic Acid Drug Major Product Offerings 7.15.4 Arrowhead Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.15.5 Arrowhead Key News & Latest Developments 7.16 Silence Therapeutics 7.16.1 Silence Therapeutics Company Summary 7.16.2 Silence Therapeutics Business Overview 7.16.3 Silence Therapeutics Small Nucleic Acid Drug Major Product Offerings 7.16.4 Silence Therapeutics Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.16.5 Silence Therapeutics Key News & Latest Developments 7.17 Dicerna 7.17.1 Dicerna Company Summary 7.17.2 Dicerna Business Overview 7.17.3 Dicerna Small Nucleic Acid Drug Major Product Offerings 7.17.4 Dicerna Small Nucleic Acid Drug Revenue in Global Market (2018-2023) 7.17.5 Dicerna Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
